Cargando…
Three-year follow-up of visual outcome and quality of life in patients with age-related macular degeneration
BACKGROUND: The purpose of this study was to evaluate the visual outcome and self-reported vision-targeted health status in patients treated with intravitreal ranibizumab for wet age-related macular degeneration (AMD). METHODS: A total of 51 eyes from 50 patients aged 76 ± 7 years, with wet AMD not...
Autores principales: | Rung, Lena, Lövestam-Adrian, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589196/ https://www.ncbi.nlm.nih.gov/pubmed/23467557 http://dx.doi.org/10.2147/OPTH.S41585 |
Ejemplares similares
-
No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration
por: Schroeder, Marion, et al.
Publicado: (2017) -
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
por: Schroeder, Marion, et al.
Publicado: (2022) -
Twelve per cent of 6142 eyes treated for neovascular age‐related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)
por: Schroeder, Marion, et al.
Publicado: (2019) -
What about the fellow eye in treatment of neovascular age‐related macular degeneration? Analysis of data from the Swedish macula register
por: Lövestam Adrian, Monica, et al.
Publicado: (2022) -
Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
por: Razi, Faraz, et al.
Publicado: (2016)